Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Antibiotics and Probiotics Prophylaxis for Recurrent Urinary Tract Infection in Children

  • Lee, Jung Won (Department of Pediatrics, Ewha Womans University School of Medicine)
  • Received : 2016.02.02
  • Accepted : 2016.04.12
  • Published : 2016.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Since many years, continuous low dose antibiotic prophylaxis (CAP) has been used for children at a risk for recurrent urinary tract infection (UTI), especially those with vesicoureteral reflux (VUR). The incidence of recurrent UTI has been shown to be higher in children with VUR with bladder and bowel dysfunction (BBD) than in those with VUR without BBD. Therefore, CAP has been recommended for children with BBD and VUR because of the increased risk of UTI. However, the use of CAP has become highly controversial because of bacterial resistance developed due to antibiotic over-usage. The preventive effects of probiotics have been proved in various adult urogenital infections, and the antimicrobial activities of lactobacilli against uropathogens have been demonstrated in previous in vitro studies. However, a critical assessment of their efficacy in children with UTI is lacking. The importance of the use of urogenital probiotics is that it is a natural approach that replenishes the depleted normal flora to create a better environment to fight off uropathogens. Probiotics have a great potential, particularly today with the increasing threat of antibiotic-resistant microorganisms.

Keywords

References

  1. Subcommittee on urinary tract infection, steering committee on quality improvement and management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011;128:595-610. https://doi.org/10.1542/peds.2011-1330
  2. Elder JS, Peters CA, Arant BS Jr, Ewalt DH, Hawtrey CE, Hurwitz RS et al. Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol 1997;157:1846-51. https://doi.org/10.1016/S0022-5347(01)64882-1
  3. Williams GJ, Wei L, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 2006; 3:CD001534.
  4. Mattoo TK. Evidence for and against urinary prophylaxis in vesicourethral reflux. Pediatr Nephrol 2010;25:2379-82. https://doi.org/10.1007/s00467-010-1632-9
  5. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006;117:626-32. https://doi.org/10.1542/peds.2005-1362
  6. Roussey-Kesler G, Gadjos V, Idres N, Horen B, Ichay L, Leclair MD, et al. Antibioic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: Results from a prospective randomized study. J Urol 2008;179:674-9.
  7. Pennesi M, Travan L, Peratoner L, Bordugo A, Cattaneo A, Ronfani L et al. North East Italy prophylaxis in VUR study groups. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, conrolled trial. Pediatrics 2008;121:e1489-94. https://doi.org/10.1542/peds.2007-2652
  8. Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, non-inferiority trial. Pediatrics 2008;122:1064-71. https://doi.org/10.1542/peds.2007-3770
  9. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003;88:444-5. https://doi.org/10.1136/adc.88.5.444
  10. Evaluation of health and nutritional properties of probiotics in food including powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United States and World Health Organization Expert consultation Report. Available at http://www.fao.org/es/ESN/Probio/probio.html2001.Cordoban, Argentina, 1-4 October 2001.
  11. Craig JC, Simpson JM, Wiliams GJ, Lowe A, Reynolds GJ, McTaggart SJ. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Eng J Med 2009;361:1748-59. https://doi.org/10.1056/NEJMoa0902295
  12. Branstrom P, Neveus T, Sixt R, Stokland E, Jodal U, Hansson S. The Swedish reflux trial in children: IV. Renal damage. J Urol 2010;184:292-7. https://doi.org/10.1016/j.juro.2010.01.060
  13. Peters CA, Skoog SJ, Arant BS, Copp HL, Elder JS, Hudson RG, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010;84:1134-44.
  14. Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndrome, primary vesicoureteral reflux and urinary tract infection in children. J Urol 1998;160:1019-22. https://doi.org/10.1016/S0022-5347(01)62686-7
  15. Chen JJ, Wenyang M, Homayoon K. A multivariate analysis of dysfunctional elimination and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol 2004;171:1907-10. https://doi.org/10.1097/01.ju.0000120288.82950.a2
  16. Avlan D, Gundogdu G, Taskinlar H, Delibas A, Nayci A. Relationship among vesicoureteral reflux, urinary tract infection and renal injury in children with non-neurogenic lower urinary tract dysfunction. J Pediatr Urol 2011;7:612-5. https://doi.org/10.1016/j.jpurol.2011.05.002
  17. Van Batavia JP, Ahn JJ, Fast AM, Combs AJ, Glassberg KI. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction. J Urol 2013;190:1495-500. https://doi.org/10.1016/j.juro.2013.02.016
  18. Matsuzaki T, Chin J. Modulating immnune response with probiotic bacteria. Immunol Cell Biol 2000;78:67-73. https://doi.org/10.1046/j.1440-1711.2000.00887.x
  19. Amdekar S, Singh V, Singh DD. Probiotic Therapy: Immunomodulating approach toward urinary tract infection. Curr Microbiol 2011;63:484-90. https://doi.org/10.1007/s00284-011-0006-2
  20. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infection. Can J Microbiol 1988;34:49-52.
  21. Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in woman with recurrent urinary tract infections. J Infect Dis 1998;178:446-50. https://doi.org/10.1086/515635
  22. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of L. rhamnosus GR-1 and L. fermentum RC-14 significantly laters vaginal flora: randomized, placebo-controlled trial in 64 healthy woman. FEMS Immunol Med Microbiol 2003;35:131-4. https://doi.org/10.1016/S0928-8244(02)00465-0
  23. Reid G, Chan RC, Bruce AW, Costerton JW. Prevention of urinary tract infection in rats with indigenous Lactobacillus casei strain. Infect Immune 1985;49:320-4.
  24. Asahara T, Nomoto K, Watanuki M, Yokokura T. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrobial Agents Chemother 2001;45:1751-60. https://doi.org/10.1128/AAC.45.6.1751-1760.2001
  25. Fraga M, Scavone P, Zunino P. Preventive and therapeutic administration of an indigenous lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Antonie Van Leeuwenhoek 2005;88:25-34. https://doi.org/10.1007/s10482-004-5475-x
  26. Marild S, Hansson S, Jodal U, Oden A, Svedberg K. Protective effect of breastfeeding against urinary tract infection. Acta Paediatr 2004;93:164-8. https://doi.org/10.1111/j.1651-2227.2004.tb00699.x
  27. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8. https://doi.org/10.1159/000063096
  28. Gerasimov SV. Probiotic prophylaxis in pediatric recurrent urinary tract infection. Clin Pediatr 2004;43:95-8. https://doi.org/10.1177/000992280404300113
  29. Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteralreflux. Pediatr Nephrol 2007;22:1315-20. https://doi.org/10.1007/s00467-007-0507-1
  30. Lee JW, Shim YH, Lee SJ. Lactobacillus colonization status in infants with urinary tract infection. Pediatr Nephrol 2009;24:135-9. https://doi.org/10.1007/s00467-008-0974-z

Cited by

  1. Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review vol.22, pp.8, 2017, https://doi.org/10.3390/molecules22081255